Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ): Levofloxacin eye drops have obtained a drug registration certificate.
Xidian Pharmaceutical (301130.SZ) published an announcement that the company recently received a notice from the National Medical Products Administration (referred to as "").
Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ) announced that the company recently received the drug registration certificate for levofloxacin eye drops issued by the National Medical Products Administration (referred to as the "NMPA").
Levofloxacin eye drops are used to treat infectious diseases caused by sensitive bacteria, such as blepharitis, meibomian gland inflammation, dacryocystitis, conjunctivitis, chalazion, keratitis, etc.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
